ESC 365 - When to consider AF ablation: outcome and survival in specific cohorts – discussion.

ESC Professional Premium Access

When to consider AF ablation: outcome and survival in specific cohorts – discussion.

Session: When to consider AF ablation: outcome and survival in specific cohorts

Topic: Treatment

Event: ESC Congress 2022

Congress Presentation

Add to my library

4 more presentations in this session

Does first line atrial fibrillation ablation improve survival in HFrEF?

Speaker: Professor J. Piccini (Durham, US)

Does first line atrial fibrillation ablation improve survival in HFpEF?

Speaker: Professor G. Hindricks (Berlin, DE)

Does first line AF ablation improve outcome in hypertrophic cardiomyopathy patients?

Speaker: Doctor A. Creta (London, GB)

Does first line AF ablation improve outcome in asymptomatic patients?

Speaker: Professor K. Chun (Frankfurt, DE)

Access the full session

When to consider AF ablation: outcome and survival in specific cohorts

Speakers: Professor J. Piccini, Professor G. Hindricks, Doctor A. Creta, Professor K. Chun

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources